V. Systemic and local infection and immunity. The role of bacteria in burn mortality.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001419:Bacteria / Q000472:pathogenicity*; D002056:Burns / Q000188:drug therapy / Q000382:microbiology / Q000401:mortality*; D004731:Endotoxins; D004926:Escherichia coli; D005260:Female; D005856:Germ-Free Life; D008297:Male; D008722:Methods; D051379:Mice; D010325:Pasteurella; D011511:Proteus; D011550:Pseudomonas aeruginosa; D018805:Sepsis; D012760:Shigella; D012965:Sodium Chloride / Q000627:therapeutic use; D013291:Streptococcus; D013411:Sulfadiazine / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D004731:Endotoxins; D013411:Sulfadiazine; D012965:Sodium Chloride